AzTrials
AzTrials

Respiratory InsufficiencyOWEDNCT02539732

Prediction of Outcome of Weaning From Mechanical Ventilation Using the Electrical Activity of the Diaphragm

An observational study of Respiratory Insufficiency, run by Unity Health Toronto at 3 sites in 3 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Several types of spontaneous breathing trials (SBTs) have been proposed to evaluate when a patient is ready to be weaned from the ventilator based on breathing pattern measurements. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Respiratory Insufficiency
How many people
110 participants
Where
3 sitesin 3 countries
Study dates
Sep 2015to Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Mechanically ventilated Intensive Care Unit patients who are ready to undergo a Spontaneous Breathing Trial.

Who may be able to join

  • Patients ready to undergo an SBT based on the decision of the clinical team.
  • Patients ventilated for at least 24 hours

Who cannot join

  • Patients younger than 18 years-old
  • Contraindication to NAVA catheter insertion (e.g., recent surgery, bleeding)
  • Central Neurological disorder (hemorrhage, tumor, massive stroke, etc.) heavily influencing breathing pattern
  • Surgical patients expected to be extubated within 12 hours.

Trial locations and contacts

3 sites in 3 countries.

Laurent J. Brochard, MD contact

416-864-6060 ext. 5686

BrochardL@smh.ca

3 sites in 3 countries

Canada1 site, 1 recruiting
  • St. Michael's Hospital

    Toronto, Ontario, M5B 1W8

    Laurent J. Brochard, MD, 416-864-6060 ext. 5686, brochardl@smh.ca

    Recruiting

Other trials in Canada

France1 site, 1 recruiting
  • Centre Hospitalier Universitaire Angers

    Angers, 49933

    Alain Mercat, MD, +33241353815, AlMercat@chu-angers.fr

    Francois Beloncle, MD, +33241353815, francois.beloncle@univ-angers.fr

    Not yet recruiting

Other trials in France

Italy1 site, 1 recruiting
  • Azienda Ospedaliero - Universitaria OORR Ospedali Riuniti di Foggia

    Foggia, 71122

    Gilda Cinnella, MD, +39 0881 73 23 07, gilda.cinnella@unifg.it

    Recruiting

Other trials in Italy

About this study

Several types of spontaneous breathing trials (SBTs) have been proposed to evaluate when a patient is ready to be weaned from the ventilator based on breathing pattern measurements. The T-piece technique allows clinicians to calculate breathing patterns accurately but many prefer to use minimal levels of assistance, which unfortunately modifies breathing pattern. The interest of Neurally Adjusted Ventilatory Assist (NAVA) is that tidal volume (Vt) supposedly represents what the patient really wants: without disconnecting the patient from the ventilator, it may be possible to determine what is the real need and whether the patient is able to maintain Vt without support. The aims of the study are as follows: to test whether the changes in Vt after the removal of a standardized level of NAVA assistance (ΔVt) can predict weaning outcome; to compare the proposed titration of effort in NAVA (occlusion) with Patient-Ventilator Breath Contribution (PVBC) and titration using the Pmusc/Eadi index (PEI) relating the pressure generated by the respiratory muscles (muscular pressure; Pmusc) to the electrical activity of the diaphragm (EAdi); to assess the effect of PEEP on the change in Vt; and to evaluate EAdi after extubation. Patients ventilated for at least 24 hours who are ready to undergo an SBT will be included. Patients younger than 18 years of age and/or who have a contraindication to NAVA catheter insertion and/or surgical patients expected to be extubated within 12 hours will be excluded. After a baseline inclusion period with the pre-enrollment mode of ventilation, the standardized NAVA level will be applied for 20 minutes, during which both Patient-Ventilator Breath Contribution (PVBC) and PEI will be calculated. After the NAVA trial, a period of Continuous Positive Airway Pressure (CPAP) 5 (2-3 minutes) followed by a period of CPAP 0 (2-3 minutes) (both with NAVA gain 0) will be performed in order to record the difference with Vt during standardized NAVA (ΔVt). At the end of this period, the patient will be switched back to the baseline settings for 30 minutes-3 hours. After this period, the patient will perform an SBT with CPAP 0 or CPAP 5 for 1 hour. At the end of the SBT, the attending physician will decide whether or not to extubate the patient according to standard criteria and blinded to the ΔVt results. Ultimately, patients will be classified as "success" or "failure" and the ΔVt will be compared between these two groups.

Keywords
Weaning, Spontaneous breathing trial, Neurally-adjusted ventilator assist, Electrical activity of the diaphragm
Medical subject headings
Respiratory Insufficiency

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in tidal volume after removing a standardized level of NAVA assistance.

    Measured: Up to 3 hours

Secondary outcomes (3)
  1. Comparison of Pmusc estimated by an occlusion technique, PVBC, and PEI.

    Measured: Up to 3 hours

  2. Change in tidal volume from PEEP of 5 centimeters of water (cmH2O) to zero PEEP.

    Measured: Up to 3 hours

  3. Change in EAdi during NAVA mode, CPAP, and after extubation.

    Measured: Up to 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Sep 2015 (estimated)
  2. Study startSep 2015
  3. Primary completionDec 2021 (estimated)
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02539732
Sponsor's protocol ID
REB# 15-214
Acronym
OWED
Status last verified
Jun 2021
First submitted
27 Aug 2015
Last updated
29 Jun 2021
Results posted
No
Data monitoring committee
No

Publications

  • Yang KL, Tobin MJ. A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation. N Engl J Med. 1991 May 23;324(21):1445-50. doi: 10.1056/NEJM199105233242101.

    PubMed 2023603
  • Bellani G, Mauri T, Coppadoro A, Grasselli G, Patroniti N, Spadaro S, Sala V, Foti G, Pesenti A. Estimation of patient's inspiratory effort from the electrical activity of the diaphragm. Crit Care Med. 2013 Jun;41(6):1483-91. doi: 10.1097/CCM.0b013e31827caba0.

    PubMed 23478659

Questions about this trial

What is this clinical trial studying?

An observational study of Respiratory Insufficiency, run by Unity Health Toronto at 3 sites in 3 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Canada, France, Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Laurent J. Brochard, MD (416-864-6060 ext. 5686, BrochardL@smh.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in tidal volume after removing a standardized level of NAVA assistance. (time frame: Up to 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02539732, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in